ARWRUSDT

- %

Dernier prix

0,000000% / 00:00:00

Graphique

Carnet d'ordres

Trades au marché

Actualités

ARWR/USDT Perpetual Futures

Dernier prix: 87.0000
Prix repère: --
Variation 24 h: --
Haut 24 h: --
Bas 24 h: --
Vol. 24 h: --

Infos - ARWR

Capitalisation du marché: --
Offre en circulation: --
Offre totale: --
Offre maximale: --
Date d'émission: --

À propos

Arrowhead Pharmaceuticals, Inc. has developed a drug that treats intractable diseases by inhibiting the genes that cause them, thus silencing the genes. Arrowhead therapy utilizes a wide range of RNA chemicals and efficient delivery methods to trigger RNA interference mechanisms, inducing rapid, deep, and durable knockout of target genes. RNA interference (RNAi) is a mechanism present in living cells that inhibits the expression of specific genes, thereby affecting the production of specific proteins. RNAi is considered one of the most important recent discoveries in life sciences, with the potential to revolutionize medicine. The discoverers of RNAi were awarded the Nobel Prize in 2006 for their work. Arrowhead Pharmaceuticals, Inc.'s RNAi-based therapy utilizes this natural pathway of gene silencing.